Aclaris therapeutics reports third quarter 2020 financial results and provides a corporate update

Wayne, pa., nov. 04, 2020 (globe newswire) -- aclaris therapeutics, inc. (nasdaq: acrs), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced its financial results for the third quarter of 2020 and provided a corporate update.
ACRS Ratings Summary
ACRS Quant Ranking